AC Immune SA (ACIU)
2.90
+0.04
(+1.40%)
USD |
NASDAQ |
Aug 25, 10:02
AC Immune Gross Profit Margin (Quarterly) : 0.00% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00% |
| March 31, 2026 | 0.00% |
| December 31, 2025 | 0.00% |
| September 30, 2025 | 0.00% |
| June 30, 2025 | 0.00% |
| March 31, 2025 | 0.00% |
| December 31, 2024 | 0.00% |
| September 30, 2024 | 0.00% |
| June 30, 2024 | 0.00% |
| March 31, 2024 | |
| December 31, 2023 | 0.00% |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 0.00% |
| September 30, 2022 | 0.00% |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 |
| Date | Value |
|---|---|
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 87.80% |
| CRISPR Therapeutics AG | -337.8% |
| Idorsia Ltd. | 72.13% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -87.08% |
| Return on Assets | -26.97% |
| Return on Invested Capital | -79.86% |
| Profit Margin (Quarterly) | 12.40% |
| Operating Margin (Quarterly) | 7.26% |
| Return on Net Operating Assets | -69.16% |